Bora CDMO Bora CDMO

X

Find Radio Compass News for Aripiprazole Lauroxil

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES
left grey arrow
right gray arrow
  • SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 1064MG/3.9ML (272.82MG/ML)
  • SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 441MG/1.6ML (275.63MG/ML)
  • SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 662MG/2.4ML (275.83MG/ML)
  • SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 882MG/3.2ML (275.63MG/ML)
  • SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 675MG/2.4ML (281.25MG/ML)

https://www.prnewswire.co.uk/news-releases/journal-of-clinical-psychiatry-publishes-data-from-alkermes-alpine-study-in-patients-with-schizophrenia-803854050.html

PRNEWSWIRE
20 May 2020

https://www.prnewswire.com/news-releases/alkermes-announces-expansion-of-patient-services-and-provider-network-to-support-uninterrupted-access-to-aristada-and-vivitrol-during-covid-19-crisis-301056231.html

PR NEWSWIRE
11 May 2020

https://www.reuters.com/article/us-alkermes-study/alkermes-says-long-acting-drugs-could-help-schizophrenics-stay-on-medication-longer-idUSKCN1RL19O

Saumya Joseph REUTERS
10 Apr 2019

https://www.fiercebiotech.com/biotech/longtime-alkermes-exec-elliot-ehrich-joins-expansion-therapeutics

Amirah Al Idrus FIERCE BIOTECH
13 Nov 2018

http://www.pharmabiz.com/NewsDetails.aspx?aid=109802&sid=2

PHARMABIZ
04 Jul 2018

http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-newsArticle&ID=2356744

PRESS RELEASE
02 Jul 2018

http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2350407

PRESS RELEASE
23 May 2018

http://www.businesswire.com/news/home/20171116005137/en/Alkermes%E2%80%99-New-Drug-Application-Investigational-Product-Designed/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J

BUSINESSWIRE
16 Nov 2017

http://www.businesswire.com/news/home/20171026005713/en/Alkermes-Initiate-New-Clinical-Study-Evaluating-ARISTADA%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J

BUSINESSWIRE
26 Oct 2017

http://www.bostonglobe.com/business/2016/10/20/alkermes-stock-climbs-positive-test-results-for-antidepressant/g4bWeMg3SEwogvtSor63UO/story.html?

Robert Weisman BOSTON GLOBE
21 Oct 2016
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY